ArticleGenes & diseases2021

Integrated chromatin and transcriptomic profiling of patient-derived colon cancer organoids identifies personalized drug targets to overcome oxaliplatin resistance.

Kuei-Ling Tung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.